2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfia
|
ENSMUSG00000028565.12 | nuclear factor I/A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfia | mm10_v2_chr4_+_97777780_97777834 | -0.71 | 9.1e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_128206346 | 3.38 |
ENSMUST00000033049.7
|
Cox6a2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr6_+_78380700 | 3.07 |
ENSMUST00000101272.1
|
Reg3a
|
regenerating islet-derived 3 alpha |
chr3_+_138277489 | 2.38 |
ENSMUST00000004232.9
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr3_-_129332713 | 2.30 |
ENSMUST00000029658.7
|
Enpep
|
glutamyl aminopeptidase |
chr5_+_66968416 | 2.22 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr2_-_129699833 | 2.21 |
ENSMUST00000028883.5
|
Pdyn
|
prodynorphin |
chr13_-_71963713 | 2.08 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr1_+_132880273 | 1.99 |
ENSMUST00000027706.3
|
Lrrn2
|
leucine rich repeat protein 2, neuronal |
chr6_-_126166726 | 1.96 |
ENSMUST00000112244.2
ENSMUST00000050484.7 |
Ntf3
|
neurotrophin 3 |
chr1_-_162898665 | 1.94 |
ENSMUST00000111510.1
ENSMUST00000045902.6 |
Fmo2
|
flavin containing monooxygenase 2 |
chr11_+_96931387 | 1.80 |
ENSMUST00000107633.1
|
Prr15l
|
proline rich 15-like |
chr11_+_54902917 | 1.77 |
ENSMUST00000149324.1
|
Gpx3
|
glutathione peroxidase 3 |
chr3_-_57847478 | 1.76 |
ENSMUST00000120289.1
ENSMUST00000066882.8 |
Pfn2
|
profilin 2 |
chr3_-_8667033 | 1.73 |
ENSMUST00000042412.3
|
Hey1
|
hairy/enhancer-of-split related with YRPW motif 1 |
chr7_-_101864093 | 1.71 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr4_+_82065855 | 1.68 |
ENSMUST00000151038.1
|
Gm5860
|
predicted gene 5860 |
chr2_+_118663235 | 1.68 |
ENSMUST00000099557.3
|
Pak6
|
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr7_+_113207465 | 1.64 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr6_-_78468863 | 1.58 |
ENSMUST00000032089.2
|
Reg3g
|
regenerating islet-derived 3 gamma |
chrX_+_164436987 | 1.56 |
ENSMUST00000036858.4
|
Asb11
|
ankyrin repeat and SOCS box-containing 11 |
chr1_+_88070765 | 1.54 |
ENSMUST00000073772.4
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chrX_-_108664891 | 1.53 |
ENSMUST00000178160.1
|
Gm379
|
predicted gene 379 |
chr11_+_78324200 | 1.51 |
ENSMUST00000102478.3
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr5_+_21372642 | 1.47 |
ENSMUST00000035799.5
|
Fgl2
|
fibrinogen-like protein 2 |
chr15_-_101054399 | 1.47 |
ENSMUST00000178140.1
|
Fignl2
|
fidgetin-like 2 |
chr7_+_131032061 | 1.46 |
ENSMUST00000084509.3
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr18_+_20665250 | 1.45 |
ENSMUST00000075312.3
|
Ttr
|
transthyretin |
chr7_+_141078188 | 1.45 |
ENSMUST00000106039.2
|
Pkp3
|
plakophilin 3 |
chr19_+_16956110 | 1.41 |
ENSMUST00000087689.4
|
Prune2
|
prune homolog 2 (Drosophila) |
chr6_+_78370877 | 1.36 |
ENSMUST00000096904.3
|
Reg3b
|
regenerating islet-derived 3 beta |
chr17_-_6948283 | 1.32 |
ENSMUST00000024572.9
|
Rsph3b
|
radial spoke 3B homolog (Chlamydomonas) |
chr7_-_46179929 | 1.30 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr8_+_124576105 | 1.28 |
ENSMUST00000093033.5
ENSMUST00000133086.1 |
Capn9
|
calpain 9 |
chr12_-_44210061 | 1.28 |
ENSMUST00000015049.3
|
Dnajb9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr14_+_55854115 | 1.28 |
ENSMUST00000168479.1
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr7_+_35555367 | 1.27 |
ENSMUST00000181932.1
|
B230322F03Rik
|
RIKEN cDNA B230322F03 gene |
chr4_-_155992604 | 1.23 |
ENSMUST00000052185.3
|
B3galt6
|
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 |
chr5_+_66745835 | 1.21 |
ENSMUST00000101164.4
ENSMUST00000118242.1 ENSMUST00000119854.1 ENSMUST00000117601.1 |
Limch1
|
LIM and calponin homology domains 1 |
chr16_-_23890805 | 1.18 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr1_-_134234492 | 1.18 |
ENSMUST00000169927.1
|
Adora1
|
adenosine A1 receptor |
chr7_+_27195781 | 1.17 |
ENSMUST00000108379.1
ENSMUST00000179391.1 |
BC024978
|
cDNA sequence BC024978 |
chr6_-_78378851 | 1.14 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr10_+_5639210 | 1.13 |
ENSMUST00000019906.4
|
Vip
|
vasoactive intestinal polypeptide |
chr1_-_162898484 | 1.13 |
ENSMUST00000143123.1
|
Fmo2
|
flavin containing monooxygenase 2 |
chr15_-_75747922 | 1.13 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr17_-_63863791 | 1.12 |
ENSMUST00000050753.3
|
A930002H24Rik
|
RIKEN cDNA A930002H24 gene |
chr17_+_26933070 | 1.12 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chrX_-_7574120 | 1.12 |
ENSMUST00000045924.7
ENSMUST00000115742.2 ENSMUST00000150787.1 |
Ppp1r3f
|
protein phosphatase 1, regulatory (inhibitor) subunit 3F |
chr9_-_51278540 | 1.11 |
ENSMUST00000114427.3
|
Gm684
|
predicted gene 684 |
chr4_-_42661893 | 1.11 |
ENSMUST00000108006.3
|
Il11ra2
|
interleukin 11 receptor, alpha chain 2 |
chr11_+_69095217 | 1.11 |
ENSMUST00000101004.2
|
Per1
|
period circadian clock 1 |
chr11_-_102897123 | 1.10 |
ENSMUST00000067444.3
|
Gfap
|
glial fibrillary acidic protein |
chr11_+_61485431 | 1.09 |
ENSMUST00000064783.3
ENSMUST00000040522.6 |
Mfap4
|
microfibrillar-associated protein 4 |
chr9_-_119341390 | 1.05 |
ENSMUST00000139870.1
|
Myd88
|
myeloid differentiation primary response gene 88 |
chr17_-_46144156 | 1.03 |
ENSMUST00000024762.2
|
Rsph9
|
radial spoke head 9 homolog (Chlamydomonas) |
chr2_-_103303158 | 1.01 |
ENSMUST00000111176.2
|
Ehf
|
ets homologous factor |
chr12_-_80132802 | 1.01 |
ENSMUST00000180643.1
|
2310015A10Rik
|
RIKEN cDNA 2310015A10 gene |
chr8_-_105943382 | 1.00 |
ENSMUST00000038896.7
|
Lcat
|
lecithin cholesterol acyltransferase |
chr6_+_125145235 | 1.00 |
ENSMUST00000119527.1
ENSMUST00000088276.6 ENSMUST00000051171.7 ENSMUST00000117675.1 |
Iffo1
|
intermediate filament family orphan 1 |
chr5_+_66968559 | 0.99 |
ENSMUST00000127184.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr11_+_28853189 | 0.97 |
ENSMUST00000020759.5
|
Efemp1
|
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
chr3_-_90514250 | 0.97 |
ENSMUST00000107340.1
ENSMUST00000060738.8 |
S100a1
|
S100 calcium binding protein A1 |
chr19_+_8850785 | 0.96 |
ENSMUST00000096257.2
|
Lrrn4cl
|
LRRN4 C-terminal like |
chr5_+_102768771 | 0.96 |
ENSMUST00000112852.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr7_+_141079759 | 0.95 |
ENSMUST00000066873.4
ENSMUST00000163041.1 |
Pkp3
|
plakophilin 3 |
chr1_-_158814469 | 0.94 |
ENSMUST00000161589.2
|
Pappa2
|
pappalysin 2 |
chr3_+_90603767 | 0.93 |
ENSMUST00000001046.5
ENSMUST00000107330.1 |
S100a4
|
S100 calcium binding protein A4 |
chr9_+_107975529 | 0.92 |
ENSMUST00000035216.4
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr3_+_89229046 | 0.92 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr2_+_69135799 | 0.92 |
ENSMUST00000041865.7
|
Nostrin
|
nitric oxide synthase trafficker |
chrX_+_101376359 | 0.92 |
ENSMUST00000119080.1
|
Gjb1
|
gap junction protein, beta 1 |
chr3_+_89418443 | 0.91 |
ENSMUST00000039110.5
ENSMUST00000125036.1 ENSMUST00000154791.1 ENSMUST00000128238.1 ENSMUST00000107417.2 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr8_+_105413614 | 0.91 |
ENSMUST00000109355.2
|
Lrrc36
|
leucine rich repeat containing 36 |
chr4_+_102570065 | 0.91 |
ENSMUST00000097950.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr12_+_36314160 | 0.90 |
ENSMUST00000041407.5
|
Sostdc1
|
sclerostin domain containing 1 |
chr5_+_30588078 | 0.90 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr16_+_23429133 | 0.90 |
ENSMUST00000038730.6
|
Rtp1
|
receptor transporter protein 1 |
chr10_+_57784859 | 0.89 |
ENSMUST00000020024.5
|
Fabp7
|
fatty acid binding protein 7, brain |
chrX_-_57338598 | 0.88 |
ENSMUST00000033468.4
ENSMUST00000114736.1 |
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr2_+_127854628 | 0.88 |
ENSMUST00000028859.1
|
Acoxl
|
acyl-Coenzyme A oxidase-like |
chr15_+_98708187 | 0.88 |
ENSMUST00000003444.4
|
Ccdc65
|
coiled-coil domain containing 65 |
chr1_-_124045247 | 0.87 |
ENSMUST00000112603.2
|
Dpp10
|
dipeptidylpeptidase 10 |
chr2_+_164562579 | 0.85 |
ENSMUST00000017867.3
ENSMUST00000109344.2 ENSMUST00000109345.2 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chr17_-_26508463 | 0.85 |
ENSMUST00000025025.6
|
Dusp1
|
dual specificity phosphatase 1 |
chr14_+_55853997 | 0.85 |
ENSMUST00000100529.3
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr9_+_99470440 | 0.85 |
ENSMUST00000056103.4
|
1600029I14Rik
|
RIKEN cDNA 1600029I14 gene |
chr19_-_5510467 | 0.85 |
ENSMUST00000070172.4
|
Snx32
|
sorting nexin 32 |
chr5_-_52471534 | 0.85 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr6_+_125552948 | 0.84 |
ENSMUST00000112254.1
ENSMUST00000112253.1 ENSMUST00000001995.7 |
Vwf
|
Von Willebrand factor homolog |
chr16_+_38089001 | 0.83 |
ENSMUST00000023507.6
|
Gsk3b
|
glycogen synthase kinase 3 beta |
chr17_+_6689072 | 0.83 |
ENSMUST00000160483.1
|
Sytl3
|
synaptotagmin-like 3 |
chr16_-_21787796 | 0.82 |
ENSMUST00000023559.5
|
Ehhadh
|
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
chr11_+_95009852 | 0.82 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr12_-_84876479 | 0.82 |
ENSMUST00000163189.1
ENSMUST00000110254.2 ENSMUST00000002073.6 |
Ltbp2
|
latent transforming growth factor beta binding protein 2 |
chr11_+_103133333 | 0.81 |
ENSMUST00000124928.1
ENSMUST00000062530.4 |
Hexim2
|
hexamethylene bis-acetamide inducible 2 |
chr13_-_23622502 | 0.81 |
ENSMUST00000062045.2
|
Hist1h1e
|
histone cluster 1, H1e |
chr3_+_8509477 | 0.79 |
ENSMUST00000029002.7
|
Stmn2
|
stathmin-like 2 |
chr10_-_109010955 | 0.79 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
Syt1
|
synaptotagmin I |
chr17_-_31637135 | 0.79 |
ENSMUST00000118504.1
ENSMUST00000078509.5 ENSMUST00000067801.6 |
Cbs
|
cystathionine beta-synthase |
chr14_+_65970610 | 0.79 |
ENSMUST00000127387.1
|
Clu
|
clusterin |
chr4_-_49549523 | 0.78 |
ENSMUST00000029987.9
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr11_+_100859492 | 0.78 |
ENSMUST00000107356.1
|
Stat5a
|
signal transducer and activator of transcription 5A |
chr17_+_7945653 | 0.78 |
ENSMUST00000097423.2
|
Rsph3a
|
radial spoke 3A homolog (Chlamydomonas) |
chr1_-_124045523 | 0.78 |
ENSMUST00000112606.1
|
Dpp10
|
dipeptidylpeptidase 10 |
chr11_-_94474088 | 0.78 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr16_+_32735886 | 0.78 |
ENSMUST00000132475.1
ENSMUST00000096106.3 |
Muc4
|
mucin 4 |
chr7_-_45091713 | 0.78 |
ENSMUST00000141576.1
|
Rcn3
|
reticulocalbin 3, EF-hand calcium binding domain |
chr10_-_24101951 | 0.78 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr9_+_54917252 | 0.77 |
ENSMUST00000039742.7
|
Hykk
|
hydroxylysine kinase 1 |
chr18_+_37489465 | 0.77 |
ENSMUST00000055949.2
|
Pcdhb18
|
protocadherin beta 18 |
chr11_+_100859351 | 0.76 |
ENSMUST00000004145.7
ENSMUST00000133036.1 |
Stat5a
|
signal transducer and activator of transcription 5A |
chr3_-_104818224 | 0.76 |
ENSMUST00000002297.5
|
Mov10
|
Moloney leukemia virus 10 |
chr11_+_96929260 | 0.76 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
chr9_-_121759788 | 0.76 |
ENSMUST00000181325.1
|
E530011L22Rik
|
RIKEN cDNA E530011L22 gene |
chr6_+_78425973 | 0.75 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr15_-_79062866 | 0.74 |
ENSMUST00000151889.1
ENSMUST00000040676.4 |
Ankrd54
|
ankyrin repeat domain 54 |
chr10_-_24092320 | 0.74 |
ENSMUST00000092654.2
|
Taar8b
|
trace amine-associated receptor 8B |
chrX_-_155623325 | 0.73 |
ENSMUST00000038665.5
|
Ptchd1
|
patched domain containing 1 |
chr6_-_83121385 | 0.73 |
ENSMUST00000146328.1
ENSMUST00000113936.3 ENSMUST00000032111.4 |
Wbp1
|
WW domain binding protein 1 |
chr11_+_96929367 | 0.73 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr13_+_38345716 | 0.73 |
ENSMUST00000171970.1
|
Bmp6
|
bone morphogenetic protein 6 |
chr14_-_34374617 | 0.73 |
ENSMUST00000023826.4
|
Sncg
|
synuclein, gamma |
chr1_+_131599239 | 0.73 |
ENSMUST00000027690.6
|
Avpr1b
|
arginine vasopressin receptor 1B |
chr7_-_44306903 | 0.73 |
ENSMUST00000004587.9
|
Clec11a
|
C-type lectin domain family 11, member a |
chr14_+_66868850 | 0.72 |
ENSMUST00000100453.1
|
Gm5464
|
predicted gene 5464 |
chr10_+_112163621 | 0.72 |
ENSMUST00000092176.1
|
Caps2
|
calcyphosphine 2 |
chr4_+_43631935 | 0.72 |
ENSMUST00000030191.8
|
Npr2
|
natriuretic peptide receptor 2 |
chr4_+_133480126 | 0.71 |
ENSMUST00000051676.6
|
Fam46b
|
family with sequence similarity 46, member B |
chr11_-_94601862 | 0.71 |
ENSMUST00000103164.3
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr7_-_127051948 | 0.71 |
ENSMUST00000051122.5
|
Zg16
|
zymogen granule protein 16 |
chr13_-_56296551 | 0.71 |
ENSMUST00000021970.9
|
Cxcl14
|
chemokine (C-X-C motif) ligand 14 |
chr6_-_41636389 | 0.70 |
ENSMUST00000031902.5
|
Trpv6
|
transient receptor potential cation channel, subfamily V, member 6 |
chr5_+_52363925 | 0.70 |
ENSMUST00000101208.4
|
Sod3
|
superoxide dismutase 3, extracellular |
chr7_+_19083842 | 0.70 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr4_+_128058962 | 0.70 |
ENSMUST00000184063.1
|
Csmd2
|
CUB and Sushi multiple domains 2 |
chr11_-_114795888 | 0.69 |
ENSMUST00000000206.3
|
Btbd17
|
BTB (POZ) domain containing 17 |
chr6_-_54593139 | 0.69 |
ENSMUST00000046520.6
|
Fkbp14
|
FK506 binding protein 14 |
chr14_+_65970804 | 0.69 |
ENSMUST00000138191.1
|
Clu
|
clusterin |
chr5_+_30281377 | 0.68 |
ENSMUST00000101448.3
|
Drc1
|
dynein regulatory complex subunit 1 |
chr16_+_84774123 | 0.68 |
ENSMUST00000114195.1
|
Jam2
|
junction adhesion molecule 2 |
chrX_+_164140447 | 0.68 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr11_+_98383811 | 0.67 |
ENSMUST00000008021.2
|
Tcap
|
titin-cap |
chr6_-_115838412 | 0.67 |
ENSMUST00000032468.5
ENSMUST00000184428.1 |
Efcab12
|
EF-hand calcium binding domain 12 |
chr6_-_125313844 | 0.67 |
ENSMUST00000032489.7
|
Ltbr
|
lymphotoxin B receptor |
chr11_-_98400453 | 0.67 |
ENSMUST00000090827.5
|
Pgap3
|
post-GPI attachment to proteins 3 |
chr7_+_113513829 | 0.67 |
ENSMUST00000033018.8
|
Far1
|
fatty acyl CoA reductase 1 |
chr19_-_24477356 | 0.67 |
ENSMUST00000099556.1
|
Fam122a
|
family with sequence similarity 122, member A |
chr2_+_164403194 | 0.66 |
ENSMUST00000017151.1
|
Rbpjl
|
recombination signal binding protein for immunoglobulin kappa J region-like |
chr11_+_101087277 | 0.66 |
ENSMUST00000107302.1
ENSMUST00000107303.3 ENSMUST00000017945.8 ENSMUST00000149597.1 |
Mlx
|
MAX-like protein X |
chr2_+_119351222 | 0.66 |
ENSMUST00000028780.3
|
Chac1
|
ChaC, cation transport regulator 1 |
chr11_-_89302545 | 0.66 |
ENSMUST00000061728.3
|
Nog
|
noggin |
chr10_+_69219357 | 0.65 |
ENSMUST00000172261.1
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chrX_-_38252398 | 0.65 |
ENSMUST00000089056.3
ENSMUST00000089054.4 ENSMUST00000066498.7 |
Tmem255a
|
transmembrane protein 255A |
chr18_+_37484955 | 0.65 |
ENSMUST00000053856.4
|
Pcdhb17
|
protocadherin beta 17 |
chrX_-_44790179 | 0.65 |
ENSMUST00000060481.2
|
Dcaf12l1
|
DDB1 and CUL4 associated factor 12-like 1 |
chr16_+_30065333 | 0.65 |
ENSMUST00000023171.7
|
Hes1
|
hairy and enhancer of split 1 (Drosophila) |
chr2_-_25621923 | 0.65 |
ENSMUST00000028308.4
ENSMUST00000142087.1 |
Tmem141
|
transmembrane protein 141 |
chr3_+_94933041 | 0.65 |
ENSMUST00000090839.5
|
Selenbp1
|
selenium binding protein 1 |
chr7_-_25754701 | 0.65 |
ENSMUST00000108401.1
ENSMUST00000043765.7 |
Hnrnpul1
|
heterogeneous nuclear ribonucleoprotein U-like 1 |
chr11_+_59306920 | 0.64 |
ENSMUST00000000128.3
ENSMUST00000108783.3 |
Wnt9a
|
wingless-type MMTV integration site 9A |
chrX_-_106011874 | 0.64 |
ENSMUST00000033583.7
ENSMUST00000151689.1 |
Magt1
|
magnesium transporter 1 |
chr1_+_74854954 | 0.64 |
ENSMUST00000160379.2
|
Cdk5r2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr9_+_107580746 | 0.64 |
ENSMUST00000148440.1
|
Hyal3
|
hyaluronoglucosaminidase 3 |
chr15_-_98898483 | 0.64 |
ENSMUST00000023737.4
|
Dhh
|
desert hedgehog |
chr18_+_9212856 | 0.64 |
ENSMUST00000041080.5
|
Fzd8
|
frizzled homolog 8 (Drosophila) |
chr16_-_22857514 | 0.63 |
ENSMUST00000004576.6
|
Tbccd1
|
TBCC domain containing 1 |
chr7_+_123462274 | 0.63 |
ENSMUST00000033023.3
|
Aqp8
|
aquaporin 8 |
chr15_+_88982894 | 0.63 |
ENSMUST00000146993.1
ENSMUST00000015509.4 |
Mov10l1
|
Moloney leukemia virus 10-like 1 |
chr13_+_94173992 | 0.63 |
ENSMUST00000121618.1
|
Lhfpl2
|
lipoma HMGIC fusion partner-like 2 |
chr17_+_46681038 | 0.63 |
ENSMUST00000002845.6
|
Mea1
|
male enhanced antigen 1 |
chr11_-_102082464 | 0.63 |
ENSMUST00000100398.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr1_+_88055467 | 0.62 |
ENSMUST00000173325.1
|
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr17_+_35821675 | 0.62 |
ENSMUST00000003635.6
|
Ier3
|
immediate early response 3 |
chr17_-_31636631 | 0.62 |
ENSMUST00000135425.1
ENSMUST00000151718.1 ENSMUST00000155814.1 |
Cbs
|
cystathionine beta-synthase |
chr12_-_12941827 | 0.62 |
ENSMUST00000043396.7
|
Mycn
|
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
chr3_+_97628804 | 0.62 |
ENSMUST00000107050.1
ENSMUST00000029729.8 ENSMUST00000107049.1 |
Fmo5
|
flavin containing monooxygenase 5 |
chr16_-_44016387 | 0.62 |
ENSMUST00000036174.3
|
Gramd1c
|
GRAM domain containing 1C |
chr14_-_31577318 | 0.62 |
ENSMUST00000112027.2
|
Colq
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
chr15_-_83724979 | 0.61 |
ENSMUST00000171496.1
ENSMUST00000043634.5 ENSMUST00000076060.5 ENSMUST00000016907.7 |
Scube1
|
signal peptide, CUB domain, EGF-like 1 |
chr4_+_43632185 | 0.61 |
ENSMUST00000107874.2
|
Npr2
|
natriuretic peptide receptor 2 |
chr18_+_33464163 | 0.61 |
ENSMUST00000097634.3
|
Gm10549
|
predicted gene 10549 |
chr1_+_93235836 | 0.61 |
ENSMUST00000062202.7
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr11_+_103133303 | 0.61 |
ENSMUST00000107037.1
|
Hexim2
|
hexamethylene bis-acetamide inducible 2 |
chr16_+_20694908 | 0.61 |
ENSMUST00000056518.6
|
Fam131a
|
family with sequence similarity 131, member A |
chr3_-_75451818 | 0.60 |
ENSMUST00000178270.1
|
Wdr49
|
WD repeat domain 49 |
chr2_+_35282380 | 0.60 |
ENSMUST00000028239.6
|
Gsn
|
gelsolin |
chr2_+_152143552 | 0.60 |
ENSMUST00000089112.5
|
Tcf15
|
transcription factor 15 |
chr11_-_102897146 | 0.60 |
ENSMUST00000077902.4
|
Gfap
|
glial fibrillary acidic protein |
chr11_-_120624973 | 0.60 |
ENSMUST00000106183.2
ENSMUST00000080202.5 |
Sirt7
|
sirtuin 7 |
chr11_+_49609263 | 0.60 |
ENSMUST00000020617.2
|
Flt4
|
FMS-like tyrosine kinase 4 |
chr8_+_34327910 | 0.59 |
ENSMUST00000075321.6
|
Gm4889
|
predicted gene 4889 |
chr4_-_117929726 | 0.59 |
ENSMUST00000070816.2
|
Artn
|
artemin |
chr19_+_5088534 | 0.59 |
ENSMUST00000025811.4
|
Yif1a
|
Yip1 interacting factor homolog A (S. cerevisiae) |
chr6_-_53820764 | 0.59 |
ENSMUST00000127748.2
|
Tril
|
TLR4 interactor with leucine-rich repeats |
chr5_-_138994935 | 0.58 |
ENSMUST00000046901.7
ENSMUST00000076095.7 |
Pdgfa
|
platelet derived growth factor, alpha |
chr19_+_16435616 | 0.58 |
ENSMUST00000025602.2
|
Gna14
|
guanine nucleotide binding protein, alpha 14 |
chr11_+_110399115 | 0.58 |
ENSMUST00000020949.5
ENSMUST00000100260.1 |
Map2k6
|
mitogen-activated protein kinase kinase 6 |
chr6_+_112273758 | 0.58 |
ENSMUST00000032376.5
|
Lmcd1
|
LIM and cysteine-rich domains 1 |
chr11_-_69695521 | 0.57 |
ENSMUST00000181261.1
|
Tnfsf12
|
tumor necrosis factor (ligand) superfamily, member 12 |
chr16_+_97356721 | 0.57 |
ENSMUST00000047275.6
|
Bace2
|
beta-site APP-cleaving enzyme 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.6 | 3.0 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.6 | 2.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.5 | 2.1 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.5 | 1.4 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.5 | 4.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.3 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.4 | 1.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.4 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 3.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 1.2 | GO:0042323 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.4 | 2.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.5 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.4 | 2.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.3 | 1.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 0.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.3 | 1.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 1.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 0.8 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 1.1 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 1.1 | GO:1990401 | embryonic lung development(GO:1990401) |
0.3 | 2.1 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.1 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 1.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.2 | 1.5 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.2 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 2.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.7 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.2 | 0.2 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.7 | GO:0035995 | skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
0.2 | 0.4 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.9 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 1.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.2 | 1.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.2 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 2.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 2.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:1905072 | cardiac jelly development(GO:1905072) |
0.2 | 0.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.8 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 1.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.2 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.2 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.2 | 0.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.5 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.9 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.3 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.2 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.5 | GO:2000845 | negative regulation of glucagon secretion(GO:0070093) positive regulation of testosterone secretion(GO:2000845) |
0.2 | 0.3 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.2 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.5 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.2 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 1.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.3 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.1 | 0.7 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.7 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 0.8 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.5 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 1.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) maintenance of Golgi location(GO:0051684) |
0.1 | 0.6 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.4 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 0.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.3 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.5 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 2.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.8 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.4 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.4 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.1 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 1.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.5 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 1.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.8 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:0033377 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.1 | 0.5 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.4 | GO:0021658 | rhombomere 3 morphogenesis(GO:0021658) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.2 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.3 | GO:0045917 | positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.2 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.2 | GO:2000040 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.2 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.1 | 0.2 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.9 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:2001015 | skeletal muscle satellite cell activation(GO:0014719) optic nerve morphogenesis(GO:0021631) negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
0.1 | 1.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.3 | GO:0072386 | stress granule disassembly(GO:0035617) plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.5 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.2 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.1 | 0.2 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.9 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.9 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.4 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.0 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.0 | 0.6 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.4 | GO:0015812 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 0.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric loop of Henle development(GO:0072236) |
0.0 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.0 | 0.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.4 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.7 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 1.6 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.0 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.3 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) observational learning(GO:0098597) |
0.0 | 0.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 1.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.6 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.3 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.0 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 1.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 1.0 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.1 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.0 | 0.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 4.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.3 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.0 | 0.9 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.3 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 2.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.5 | GO:0036019 | endolysosome(GO:0036019) |
0.2 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 2.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.2 | GO:0005940 | septin ring(GO:0005940) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.2 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 1.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 2.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 1.2 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 1.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.7 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.3 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 1.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 16.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.0 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.6 | 1.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.4 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.4 | 3.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 1.6 | GO:0070976 | TIR domain binding(GO:0070976) |
0.4 | 1.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 2.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.0 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.3 | 1.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 2.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.3 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 2.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 0.6 | GO:0071820 | N-box binding(GO:0071820) |
0.2 | 0.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 1.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.2 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.5 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.2 | 0.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.5 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 1.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 2.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 1.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.7 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 2.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 0.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.1 | 1.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.1 | 0.3 | GO:0070401 | NADP+ binding(GO:0070401) |
0.1 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 1.2 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 2.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.5 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.8 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0031893 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) vasopressin receptor binding(GO:0031893) V2 vasopressin receptor binding(GO:0031896) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 2.1 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.2 | GO:0005152 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.1 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.2 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.0 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 2.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.0 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.0 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.0 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.0 | 1.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 3.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0043120 | interleukin-8 binding(GO:0019959) tumor necrosis factor binding(GO:0043120) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 5.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 1.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 9.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 2.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 5.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 6.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 2.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 3.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 2.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |